Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial

Published:2022-06 Issue: Volume:Volume 14 Page:2007-2015
ISSN:1179-1322
Container-title:Cancer Management and Research
language:en
Short-container-title:CMAR

Author:

Wei Jia,Lu Xiaofeng,Liu Qin,Fu Yao,Liu Song,Li Lin,Liu Fangcen,Fan Xiangshan,Yang Ju,Yang Yang,Zhao Yang,Guan Wenxian,Liu Baorui

Publisher

Informa UK Limited

Subject

Oncology

Reference31 articles.

1. Epidemiology of gastric cancer: global trends, risk factors and prevention

2. The survival and the long-term trends of patients with gastric cancer in Shanghai, China

3. Gastric Cancer, Version 2.2013

4. Perioperative chemotherapy of oxaliplatin combined with S-1 (SOX) versus postoperative chemotherapy of SOX or oxaliplatin with capecitabine (XELOX) in locally advanced gastric adenocarcinoma with D2 gastrectomy: A randomized phase III trial (RESOLVE trial)

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoint inhibitors and radiotherapy in gastrointestinal cancer treatment;Український радіологічний та онкологічний журнал;2024-07-02

2. A prospective phase II clinical trial of total neoadjuvant therapy for locally advanced gastric cancer and gastroesophageal junction adenocarcinoma;Scientific Reports;2024-03-29

3. Gastric cancer with brain metastasis: from molecular characteristics and treatment;Frontiers in Oncology;2024-03-21

4. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023;Cancer Communications;2023-12-31

5. Immunoneoadjuvant therapy with immune checkpoint inhibitors of gastric cancer: an emerging exemplification;Investigational New Drugs;2023-11-16